• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The tranSMART Foundation to manage OpenBEL Project

The tranSMART Foundation to manage OpenBEL Project

December 17, 2015
CenterWatch Staff

The tranSMART Foundation, a nonprofit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, has announced that it will manage and further develop the OpenBEL project in an agreement with Selventa.

Biological Expression Language (BEL) is a language, developed by Selventa, for representing top scientific findings in a standard way to foster collaboration and sharing of those findings. OpenBEL is a member-based community focused on accelerating the pace of open source technology innovation and scientific discovery.

The OpenBEL project becomes the second main project for the tranSMART Foundation, adding to and enriching the original tranSMART software platform. Each project will remain independent, but integration between them will enhance both projects.

According to tranSMART CEO Keith Elliston, “In adding OpenBEL to the foundation, we not only begin the expansion of the foundation to advance key initiatives that foster the exchange of knowledge in biomedical research, but also bring these two projects in alignment for the direct advantage of the research community.”

William Hayes, CTO at Selventa, said, “We are delighted to have OpenBEL become part of the successful tranSMART Foundation. We believe the open source and open data community that tranSMART has created is the best environment to expand the adoption and further development of OpenBEL.”

The formal transfer of OpenBEL has been completed. The teams from both Selventa and tranSMART Foundation continue to work through the details. They are planning an OpenBEL launch event in mid-January to discuss the current tools and describe the roadmap going forward for the project.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing